nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A knock-in mouse strain facilitates dynamic tracking and enrichment of MEIS1
|
Xiang, Ping |
|
|
1 |
24 |
p. 2225-2235 |
artikel |
2 |
BRAFV600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia
|
Tsai, Yo-Ting |
|
|
1 |
24 |
p. 2147-2160 |
artikel |
3 |
Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study
|
Eissa, Hesham M. |
|
|
1 |
24 |
p. 2243-2246 |
artikel |
4 |
Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease
|
Mehrad, Borna |
|
|
1 |
24 |
p. 2217-2224 |
artikel |
5 |
Cord blood transplantation recapitulates fetal ontogeny with a distinct molecular signature that supports CD4+ T-cell reconstitution
|
Hiwarkar, Prashant |
|
|
1 |
24 |
p. 2206-2216 |
artikel |
6 |
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma
|
Karvonen, Hanna |
|
|
1 |
24 |
p. 2257-2268 |
artikel |
7 |
Editorial Board
|
|
|
|
1 |
24 |
p. i |
artikel |
8 |
Hispanic ethnicity is associated with younger age at presentation but worse survival in acute myeloid leukemia
|
Darbinyan, Karine |
|
|
1 |
24 |
p. 2120-2123 |
artikel |
9 |
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide
|
Aversa, Franco |
|
|
1 |
24 |
p. 2166-2175 |
artikel |
10 |
ITP and thrombosis: an intriguing association
|
Rodeghiero, Francesco |
|
|
1 |
24 |
p. 2280 |
artikel |
11 |
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells
|
Withers, Barbara |
|
|
1 |
24 |
p. 2193-2205 |
artikel |
12 |
Management of newly diagnosed immune thrombocytopenia: can we change outcomes?
|
Neunert, Cindy E. |
|
|
1 |
24 |
p. 2295-2301 |
artikel |
13 |
Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah's Witness experience
|
George, James N. |
|
|
1 |
24 |
p. 2161-2165 |
artikel |
14 |
Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study
|
Thordardottir, Marianna |
|
|
1 |
24 |
p. 2186-2192 |
artikel |
15 |
Patients' priorities in selecting chronic lymphocytic leukemia treatments
|
Mansfield, Carol |
|
|
1 |
24 |
p. 2176-2185 |
artikel |
16 |
Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation
|
Aldenhoven, Mieke |
|
|
1 |
24 |
p. 2236-2242 |
artikel |
17 |
Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma
|
Kim, Young Ae |
|
|
1 |
24 |
p. 2138-2146 |
artikel |
18 |
Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates
|
Kwun, Jean |
|
|
1 |
24 |
p. 2115-2119 |
artikel |
19 |
TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects
|
Tenshin, Hirofumi |
|
|
1 |
24 |
p. 2124-2137 |
artikel |
20 |
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma
|
Green, Damian J. |
|
|
1 |
24 |
p. 2247-2256 |
artikel |
21 |
The role of targeted therapy in the management of patients with AML
|
Perl, Alexander E. |
|
|
1 |
24 |
p. 2281-2294 |
artikel |
22 |
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT
|
Ho, Vincent T. |
|
|
1 |
24 |
p. 2269-2279 |
artikel |